Form 4 for OSCR Oscar Health, Inc.
Accepted 2026-06-29 16:17:05 ET · period of report 2026-06-25 · accession 0001352552-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-29 16:17 | 2026-06-25+ | OSCR | Bertolini Mark T | CEO, Dir | S - Sale | $28.94 | -1.21M | 8.99M | -12% | -$34.91M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-06-25 | S | D | 597,942 | $28.60 | 9,598,934 | D | — | — | (F1) Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.06 to $29.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. (F3) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 2 | Common | Class A Common Stock | 2026-06-25 | S | D | 17,200 | $29.08 | 9,581,734 | D | — | — | (F1) Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.06 to $29.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. (F3) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 3 | Common | Class A Common Stock | 2026-06-26 | S | D | 441,373 | $29.11 | 9,140,361 | D | — | — | (F1) Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $29.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. (F3) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 4 | Common | Class A Common Stock | 2026-06-26 | S | D | 149,795 | $29.79 | 8,990,566 | D | — | — | (F1) Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.51 to $30.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. (F3) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |